a magnifying glass

adobe pdf icon Analogic Corporation Elects Dr. Sophie Vandebroek to Its Board of Directors

Analogic Corporation Elects Dr. Sophie Vandebroek to Its Board of Directors

Analogic Corporation Elects Dr. Sophie Vandebroek to Its Board of Directors

John Tarello, Long-Term Director and Former Chairman, to Retire in July

PEABODY, Mass.–(BUSINESS WIRE)–April 16, 2008–Analogic
Corporation (NASDAQ: ALOG) announced today that Dr. Sophie Vandebroek
has been elected to the Company’s Board of Directors, effective August
1, 2008. Dr. Vandebroek, who also serves as Corporate Vice President
and Chief Technology Officer (CTO) of Xerox Corporation (NYSE: XRX)
and President of the Xerox Innovation Group, will replace John
Tarello, who has announced his retirement from the Analogic Board
effective July 31, 2008. Dr. Vandebroek is expected to be named to the
Nominating and Corporate Governance and Technology Committees of the
Board of Directors.

Dr. Vandebroek has held a number of key innovation leadership
posts over the course of her career. In her current role at Xerox,
which she assumed in 2006, Dr. Vandebroek’s responsibilities include
the oversight of Xerox’s global research centers, as well as
maximizing the company’s return on its investment in research and
technology. Dr. Vandebroek has also served as Vice President of the
Xerox Engineering Center and as Technical Advisor to the Xerox Chief
Operating Officer. In addition, she has served as Senior Vice
President and CTO of Carrier Corporation, a unit of United
Technologies Corporation and a leading global provider of air
conditioning, heating and refrigeration systems.

Dr. Vandebroek holds a Ph.D. in Electrical Engineering from
Cornell University, and a Master of Science in Electro-Mechanical
Engineering, Magna Cum Laude, from Katholieke Universiteit Leuven, in
Leuven, Belgium. She is a Fellow of the Institute of Electrical and
Electronics Engineers (IEEE) and has served as an elected member on
the IEEE Electron Devices Society Administrative Committee. She has
served on the board of many organizations, including the MEMS Industry
Group and the American Electronics Association. A Fulbright Fellow and
a Fellow of the Belgian-American Educational Foundation, Dr.
Vandebroek holds 12 U.S. patents.

James W. Green, Analogic’s President and CEO, commented, “I look
forward to working with Dr. Vandebroek. Her impressive experience
driving innovation at Xerox’s worldwide research and technology
centers will be invaluable to Analogic and our Board as we look for
new opportunities for growth as an engineering and scientific leader.”

John Tarello has been a Director since 1978, serving as Chairman
of the Board from April 2004 until November 2006 and Vice Chairman on
an interim basis from November 2006 until January 2008. Mr. Tarello
was an employee of Analogic for nearly 30 years, serving as
Controller, Vice President, Senior Vice President, Chief Financial
Officer, and Treasurer, before retiring in November 1999.

“On behalf of the Board of Directors and the entire Company, I
would like to thank John for his long and meritorious service to
Analogic,” said Ed Voboril, Analogic’s Chairman of the Board. “His
contributions, through his directorship and as an Analogic executive,
have had a long-term impact on the success of the Company. We all wish
John well.”

Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Automatic Explosives
Detection, Computed Tomography (CT), Digital Radiography (DR),
Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, and
Advanced Signal Processing. For more information, visit
www.analogic.com.

Forward-Looking Statements

Any statements in this press release about future expectations,
plans, and prospects for Analogic Corporation (the “Company”),
including statements about orders for the Company’s products,
statements about shipments and installation of the Company’s products,
and other statements containing the words “believes,” “anticipates,”
“plans,” “expects,” and similar expressions, constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results may differ
materially from those indicated by such forward-looking statements as
a result of various important factors, including risks relating to
technology development and commercialization, risks in product
development, limited demand for the Company’s products, risks
associated with competition, uncertainties associated with regulatory
agency approvals, competitive pricing pressures, downturns in the
economy, the risk of potential intellectual property litigation, and
other factors discussed in our most recent quarterly report filed with
the Securities and Exchange Commission. In addition, the
forward-looking statements included in this press release represent
the Company’s views as of the date of this release. The Company
anticipates that subsequent events and developments will cause the
Company’s views to change. However, while the Company may elect to
update these forward-looking statements at some point in the future,
the Company specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as representing
the Company’s views as of any date subsequent to the date of this
release.

CONTACT: Analogic Corporation
Jim Green, 978-326-4000
President & CEO
or
Paul M. Roberts, 978-326-4213
Director of Communications

SOURCE: Analogic Corporation